24/7 Wall St. will name its annual CEO of the Year next week. The executive will be picked from a field of ten which we will profile this week The CEOs are…
Douglas A. McIntyre Amgen Inc. (NASDAQ: AMGN) has just posted earnings. The biotech giant for anemia treatments posted $1.09 GAAP EPS and adjusted earnings of $1.23 non-GAAP EPS and $3.875 billion in revenues. First Call…
Douglas A. McIntyre These are some of the top upgrades we are seeing from Wall Street analysts this morning: Amgen (AMGN) Raised to Outperform at William Blair. Capital Product Partners (CPLP) Started as Outperform at…
According to Reuters, the federal government bailed out AIG (AIG) The Fed will loan the insurance company $85 billion for two years in exchange for a 79.9% stake. Reuters says that Barclays…
Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor. The short interest in Amgen (AMGN) dropped 22% and Calgene (CELG) fell 20%.
These are some of the key analyst upgrades and positive calls we have seen early this Monday morning with over 2 hours to open: Akamai Tech (AKAM) Raised to Buy at Jefferies.…
According to Reuters, T Boone Pickens is seeking an "army" of business leaders and citizens to back alternative energy. Reuters reports that Starbucks (SBUX) posted if first loss as a public company…
These are some of the analyst upgrades and positive calls we are seeing early this Tuesday morning: Aeropostale (ARO) Started as Buy at Goldman Sachs. Amgen (AMGN) Raised to Buy at Citigroup.…
Earnings out of Amgen Inc. (NASDAQ: AMGN) appear to be strong enough to defy any notions that the big osteoporosis news would render this particular earnings report immaterial. The biotech giant just…
Douglas A. McIntyre After today’s close, we’ll be getting earnings out of biotech giant Amgen Inc. (NASDAQ: AMGN). It’s amazing how the company’s strong osteoporosis data has suddenly gotten the company out of the gutter…
Douglas A. McIntyre These are not all of the upgrades or positive calls we have seen, but these are some calls moving shares this Monday morning: AFLAC (AFL) Raised to Outperform at Raymond James. Amgen…
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and other companies involved in various aspects of health care and medicine. Below…
Based on data from Nasdaq as of June 13, short sellers made heavy bets against tech stocks. Many investors clearly think the sector is not immune from the current economic downturn. The…
Shares of Amgen Inc. (NASDAQ: AMGN) are seeing a small gain in after-hours trading. The troubled biotech giant announced that findings from its head-to-head, double-blind trial comparing the effects of denosumab in…
Amgen (AMGN) adjusted earnings per share of $1.12 for the first quarter of 2008, an increase of 4 % compared to $1.08 for the first quarter of 2007. Adjusted net income decreased…
Douglas A. McIntyre